Lakefront Biotherapeutics | GLPG - Market Capitalization


Lakefront Biotherapeutics reported EUR1.55B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
argenx SE USD 57.63B 13.25B Jun/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
Biogen USD 31.9B 5B Jun/2026
Genmab DKK 17.1B 88.06B Jun/2026
Gilead Sciences USD 156.86B 16.13B Jun/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
GRIFOLS EUR 5.41B 181.49M Jun/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Incyte USD 22.65B 3.92B Jun/2026
Merck EUR 18.98B 27.8B Jun/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
UCB EUR 46.41B 13.94B Dec/2025
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026